高级搜索

基于人群的幽门螺杆菌筛查与治疗策略用于胃癌预防:WHO-IARC 2025年胃癌工作组报告解读

Population-Based Helicobacter pylori Screen-and-Treat Strategies for Gastric Cancer Prevention: An Interpretation of WHO–IARC 2025 Gastric Cancer Working Group Report

  • 摘要: 胃癌是全球范围内严重威胁人类生命健康的重大公共卫生问题,根除幽门螺杆菌(H. pylori)感染是开展胃癌一级预防的关键手段。2025年4月,世界卫生组织-国际癌症研究机构(WHO-IARC)发布了新版胃癌工作组报告指南,系统提出基于人群的H. pylori筛查与治疗(screen-and-treat)策略,全面阐述从需求与准备情况评估、检测与治疗方案选择、抗生素管理,到质量保障、公平促进和成本效益优化的实施要点,旨在为全球胃癌预防的实践提供科学指导。本文对该报告进行了全面梳理与深度解读,并结合我国胃癌防控实际,探讨对我国制定和实施更具成本效益的本土化人群H. pylori筛查与治疗策略的借鉴意义。

     

    Abstract: Gastric cancer remains a significant public health challenge globally, posing a severe threat to human health. Eradication of Helicobacter pylori (H. pylori) infection is the key to the primary prevention of gastric cancer. In April 2025, the World Health Organization-International Agency for Research on Cancer (WHO-IARC) released the Gastric Cancer Working Group Report. The report systematically details essential components for implementation of the population-based H. pylori screen-and-treat strategies, encompassing assessment of needs and readiness, selection of detection methods and treatment regimens, antibiotic stewardship, improvement of quality and equity, and optimization of cost-benefits, with the goal of providing scientific guidance for global gastric cancer prevention efforts. This article presents a comprehensive review and in-depth analysis of the WHO-IARC report. By considering the current landscape of gastric cancer prevention and control in China, this article explores the report's implications for developing and implementing more cost-effective, localized, population-based H. pylori screen-and-treat strategies tailored to the Chinese context.

     

/

返回文章
返回